Business Description
Qlife Holding AB
ISIN : SE0022574331
Share Class Description:
FRA:4HG0: Ordinary SharesTotal Employee Number:
3Compare
Compare
Traded in other countries / regions
QLIFE.Sweden4HG0.Germany IPO Date
2021-02-11Description
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.52 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 3.15 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -33.59 | |||||
Beneish M-Score | 2.37 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -95.2 | |||||
3-Year EBITDA Growth Rate | 88.7 | |||||
3-Year EPS without NRI Growth Rate | 88.9 | |||||
3-Year FCF Growth Rate | 88.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.25 | |||||
9-Day RSI | 39.08 | |||||
14-Day RSI | 40.75 | |||||
3-1 Month Momentum % | -21.01 | |||||
6-1 Month Momentum % | -6.9 | |||||
12-1 Month Momentum % | -50.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.48 | |||||
Quick Ratio | 2.9 | |||||
Cash Ratio | 2.27 | |||||
Days Inventory | 2604.95 | |||||
Days Sales Outstanding | 90 | |||||
Days Payable | 1345.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -500.4 | |||||
Shareholder Yield % | -66.97 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.56 | |||||
Operating Margin % | -2260.37 | |||||
Net Margin % | -2376.71 | |||||
EBITDA Margin % | -2112.98 | |||||
FCF Margin % | -2122.78 | |||||
OCF Margin % | -2122.78 | |||||
ROA % | -173.58 | |||||
ROIC % | -200.13 | |||||
3-Year ROIIC % | -39.88 | |||||
ROC (Joel Greenblatt) % | -1415.09 | |||||
ROCE % | -348.45 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 36.95 | |||||
PB Ratio | 19.27 | |||||
EV-to-EBIT | -2.79 | |||||
EV-to-EBITDA | -2.99 | |||||
EV-to-Revenue | 63 | |||||
EV-to-FCF | -3.03 | |||||
Price-to-GF-Value | 0.87 | |||||
Earnings Yield (Greenblatt) % | -35.86 | |||||
FCF Yield % | -36.37 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Qlife Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.079 | ||
| EPS (TTM) (€) | -0.166 | ||
| Beta | -24.108 | ||
| 3-Year Sharpe Ratio | 0.7 | ||
| 3-Year Sortino Ratio | 11.45 | ||
| Volatility % | 194.57 | ||
| 14-Day RSI | 40.75 | ||
| 14-Day ATR (€) | 0.002887 | ||
| 20-Day SMA (€) | 0.14525 | ||
| 12-1 Month Momentum % | -50.82 | ||
| 52-Week Range (€) | 0.0948 - 0.316 | ||
| Shares Outstanding (Mil) | 28.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Qlife Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Qlife Holding AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-10 | In 160 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-10 | In 160 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-11 | In 69 days | ||
| Third quarter earnings results for 2026 | 2026-11-11 | In 69 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-26 | 0.14 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-08-26 | 0.14 (+0.00%) | ||
| General meeting for 2026 | 2026-05-27 11:00 | 0.16 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 0.15 (+0.00%) | ||
| Annual report for 2025 | 2026-04-29 | 0.16 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-11 | 0.18 (+0.00%) |
Show
Entries
Qlife Holding AB Frequently Asked Questions
What is Qlife Holding AB(FRA:4HG0)'s stock price today?
The current price of FRA:4HG0 is €0.14. The 52 week high of FRA:4HG0 is €0.32 and 52 week low is €0.09.
When is next earnings date of Qlife Holding AB(FRA:4HG0)?
The next earnings date of Qlife Holding AB(FRA:4HG0) is 2026-11-11.
Does Qlife Holding AB(FRA:4HG0) pay dividends? If so, how much?
Qlife Holding AB(FRA:4HG0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Qlife Holding AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers